BioSpace News Archive

Cutera, Inc., a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, announced that it will report financial results for the second quarter 2020 after the market close on Thursday, August 6, 2020.

Cyprium Therapeutics, a Fortress partner company, is developing CUTX-101 for Menkes disease A rolling submission of a New Drug Application to the FDA is expected to begin in the fourth quarter of 2020

Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that they have entered into a strategic partnership whereby Catalent will provide support for the development, manufacturing, and clinical suppl

Kleo Pharmaceuticals announced today that Doug Manion, MD, Chief Executive Officer and Chairman of the Board, will be presenting a corporate overview at the Private Healthcare Company Virtual Summer Symposium, hosted by LifeSci Partners on August 4 and 5, 2020. Please click the following link to register: https://lifesci.events/SummerSymposium . Presentation Details: Date: August 5, 2020 Time: 8:30am Eastern Time About Kl

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will report second quarter 2020 financial results on Wednesday, August 5, 2020, after U.S. financial markets close. Management will host a conference call on Wednesday, August 5, 2020, at 4:30 p.m. ET to provide a general business update and to discuss second quarter 2020 financial results. To participate in the conference call, please dial 877-407-3982 (

BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced it has acquired the On.Demand™ remote patient monitoring (RPM) and coaching platform, operated by Envolve People Care, Inc., a Centene Corporation subsidiary. This acquisition adds chronic RPM and coaching solutions to BioTelemetry’s current suite of acut

Chief Operating Officer Kurt Becker to Take on Broadened Role Overseeing Global Operations and Research and Development

Sanofi (NASDAQ: SNY; EURONEXT: SAN) Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8751951-sanofi-earnings-results-q2-2020/ Q2 2020 sales results reflect the strong performance of Dupixent ® more than offset by COVID-19 related negative effects on Vaccines, General Medicines an

Rigorously and independently tested and validated, Easy Check exceeds current testing requirements for the detection of IgM/IgG antibodies to SARS-CoV-2

IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its second quarter 2020 financial and operating results on Wednesday, August 5, 2020. Following the announcement, the IVERIC bio management team will host a live conference call and webcast at 8:00 a.m. Eastern Time to discuss the Company’s financial results and provide a general business update. To participate in this conference call, dial 888-220-8451